TipRanks

Nicholas Kadysh Insider Profile

11 Followers
Nicholas Kadysh, President & Chief Executive Officer at PharmAla Biotech Holdings, Inc., holds 8.15M shares in PharmAla Biotech Holdings, Inc. (Ticker: TSE:MDMA), holds 1.13M shares in Duncan Park Holdings (Ticker: TSE:DPH), holds 1.13M shares in Psyched Wellness (Ticker: PSYCF).
tipranks
Nicholas Kadysh

Nicholas Kadysh
PharmAla Biotech Holdings, Inc. (MDMA)
President & Chief Executive Officer

Ranked #15,467 out of 109,106 Corporate Insiders

Profitable Transactions

40%
2 out of 5 Profitable Transactions

Average Return

+29.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
99.38%
0.62%
A breakdown of Nicholas Kadysh's holdings

Insider Roles

PharmAla Biotech Holdings, Inc.
(MDMA)
President & Chief Executive Officer
Psyched Wellness
(PSYCF)
Director
Roles that Nicholas Kadysh holds in companies

Most Profitable Insider Trade

Stock:
Psyched Wellness
(PSYCF)
Rating:Informative Buy
Date:May 26, 2020 - May 26, 2021
Return:+135.20%
The most profitable trade made by Nicholas Kadysh

Nicholas Kadysh's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
PharmAla Biotech Holdings, Inc.
Jun 13, 2026
President & Chief Executive Officer
Uninformative Sell
17.50K
C$2.00M
DPH
Duncan Park Holdings
―
―
―
C$112.50K
Psyched Wellness
May 26, 2020
Director
Informative Buy
7.50K
$12.38K
List of latest transactions for each holding click on a transaction to see Nicholas Kadysh's performance on stock

Nicholas Kadysh insider profile FAQ

What is the percentage of profitable transactions made by Nicholas Kadysh?
The percentage of profitable transactions made by Nicholas Kadysh is 40%.
    What is the average return per transaction made by Nicholas Kadysh?
    The average return per transaction made by Nicholas Kadysh is 29.10%.
      What stocks does Nicholas Kadysh hold?
      Nicholas Kadysh holds: TSE:MDMA, TSE:DPH, PSYCF stocks.
        What was Nicholas Kadysh’s latest transaction?
        Nicholas Kadysh latest transaction was an Uninformative Sell of C$17.50K.
          What was Nicholas Kadysh's most profitable transaction?
          Nicholas Kadysh’s most profitable transaction was an Informative Buy of PSYCF stock on May 26, 2020. The return on the trade was 135.20%.
            What is Nicholas Kadysh's role in PharmAla Biotech Holdings, Inc.?
            Nicholas Kadysh's role in PharmAla Biotech Holdings, Inc. is President & Chief Executive Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.